PDL BioPharma (PDLI) Announces Pricing of Aggregate $150M Conv. Notes Offering
Tweet Send to a Friend
PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) announced that it has agreed to sell $150.0 million aggregate principal amount of its ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
